RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

October 1, 2025

Study Completion Date

February 1, 2026

Conditions
Essential TremorParkinson Disease
Interventions
DEVICE

Unframed Virtual Cone

The patient will undergo stereotactic radiosurgery. Radiosurgery is a single non-surgical radiation treatment and will be done as an outpatient procedure. High-energy radiation will be delivered to a small, precise area of the patient's brain using a linear accelerator. A face mask (unframed) will be placed over the patient's face to keep their head from moving during the procedure. During the procedure, the study doctor will confirm the exact location that needs to be treated using x-rays and optical imaging cameras. The face mask will hold the patient's head to prevent it from moving and to focus the x-rays and aim them on a small area in the thalamus of the patient's brain. For most patients, the actual time on the radiosurgery treatment machine is 30 to 60 minutes. The face mask will be removed after the treatment.

Trial Locations (1)

35249

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03305588 - RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease | Biotech Hunter | Biotech Hunter